Suboptimal clinical response to anti-tumor necrosis factor alpha (TNFα) antibody therapy in a patient with severe rheumatoid arthritis and lymphadenopathy

Scandinavian Journal of Rheumatology

Volumn 27, Issue 4, 1998, Pages 303-305

  Saeki, Yukihiko ^a   Ohshima, Shiro ^a   Mima, Toru ^b   Sasai, Mitsuko ^a   Nishioka, Katsuhiro ^a   Shimizu, Masatoshi ^b   Suemura, Masaki ^a   McCloskey, Richard ^c   Kishimoto, Tadamitsu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b MINAMI OSAKA GENERAL HOSPITAL   (Japan)

^c CENTOCOR INC   (United States)

Author keywords

Anti TNF antibody; IL 6; Lymphadenopathy; Rheumatoid arthritis; TNF

Indexed keywords

INTERLEUKIN 6; KELIXIMAB; MESSENGER RNA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTHRITIS; ARTICLE; CASE REPORT; DISEASE SEVERITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; HUMANS; INTERLEUKIN-6; LYMPH NODES; LYMPHATIC DISEASES; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031690450     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097498442433     Document Type: Article

References (6)

1. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, et al. Randomised double blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344: 1105-10.
2. Maini RN, Elliott MJ, Brennan FM, Williams RO, Chu CQ, Paleolog E, et al. Monoclonal anti-TNFα antibody as a probe of pathogenesis and therapy of rheumatoid arthritis. Immunol Rev 1995;144:195-223.
3. Paulus HE, Egger MJ, Ward JR, Williams Hj. The Cooperative Systematic Studies of Rheumatic Disease Group. Analysis of improved in individual rheumatoid arthritis patients treated with disease modifying anti-rheumatic drugs, based on the finding in patients treated with placebo. Arthritis Rheum 1990;33:477-84.
4. Numata Y, Matsuura Y, Onishi S, Yamamoto Y, Ohno F, Tagoh H, et al. Interleukin-6 positive follicular hyperplasia in lymph node of a patient with rheumatoid arthritis. Am J Hematol 1991;36:282-4.
5. Kishimoto T. Interleukin-6 and its receptor in autoimmunity. J Autoimmun 1992;5 Suppl A:123-32.
6. Pisa EK, Pisa P, Hausson M, Wigzell H. OKT-3 induced cytokine mRNA expression in human peripheral blood mononuclear cells measured by polymerase chain reaction. Scand J Immunol 1992;36:745-9.